関連する実験動画
Updated: Feb 16, 2026
08:11
Quantitative Analysis of Chromatin Proteomes in Disease
Published on: December 28, 2012
13.7K
心血管リスクプロテオムの遺伝子構造
Mark D Benson1,2, Qiong Yang3, Debby Ngo2,4
1Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (M.D.B.).
Circulation
|December 21, 2017
まとめ
この研究では,心血管疾患のリスクに関連する血タンパク質レベルに影響を与える新しい遺伝的要因が特定されました. これらの発見は,脂質タンパク質の生物学と心血管疾患の病理学に関する新しい洞察を提供します.
科学分野:
- 遺伝学とゲノミクス
- プロテオミクス
- 心血管疾患の研究
背景:
- 心血管疾患のリスクと関連した156のヒト血タンパク質が特定されました.
- 研究の目的は,これらのリスクに関連するタンパク質の遺伝的決定因子を発見することでした.
研究 の 目的:
- 心血管疾患のリスクに関連する156のタンパク質の血レベルに関連した遺伝的変異を特定する.
- 心血管疾患の新生物学的経路を探求する
- アポリプロテインEレベルとの新しい遺伝的関連を実験的に検証する.
主な方法:
- 全ゲノム関連研究 (GWAS) とエクソーム配列分析は,人口ベースの2つのコホート (フレミングハム心臓研究の子孫とマルモダイエットとがん研究) で実施されました.
- 線形混合効果モデルを用いて,遺伝子変異と血タンパク質濃度の関連性を評価した.
- 細胞モデルシステムは,新しい遺伝的関連の実験的検証に使用されました.
主要な成果:
- GWASからの120のロカスタンパク質関連と,エクスーム配列解析からの41の関連が特定され,その多くは以前には記述されていなかった.
- 血タンパク質の変異は66%まで説明され,一般的な臨床的要因よりもはるかに多い.
- アポリポプロテインEレベルと転写因子フォスファタゼ1Gとの間の新しい関連は実験的に検証され,フォスファタゼ1GのノックダウンがアポリポプロテインEの転写とレベルを低下させたことを示しました.
結論:
- 心血管疾患のリスクに関連したタンパク質の 新種の遺伝的決定因子が何十もの発見されました
- リンパタンパク質生物学におけるフォスファタゼ1Gの新たな役割が実験的に確認された.
- 各タンパク質の公開されている全ゲノムおよびエクソーム配列データは,心血管疾患の研究のリソースとして提供されています.
関連する概念動画
01:30Coronary Artery Disease I: Introduction
1.2K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
01:29Pharmacogenomics: Identification of New Drug Targets
9
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
9
01:27Regulation of the Cardiovascular System
4.2K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
4.2K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
934
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
934
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
619
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
619
01:26Coronary Artery Disease II: Pathophysiology
559
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
559